JP2023550446A5 - - Google Patents
Info
- Publication number
- JP2023550446A5 JP2023550446A5 JP2023530329A JP2023530329A JP2023550446A5 JP 2023550446 A5 JP2023550446 A5 JP 2023550446A5 JP 2023530329 A JP2023530329 A JP 2023530329A JP 2023530329 A JP2023530329 A JP 2023530329A JP 2023550446 A5 JP2023550446 A5 JP 2023550446A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- antigen
- antibody
- cdr1
- cdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20306424 | 2020-11-20 | ||
| EP20306424.1 | 2020-11-20 | ||
| PCT/EP2021/082383 WO2022106665A1 (en) | 2020-11-20 | 2021-11-19 | Anti-cd25 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550446A JP2023550446A (ja) | 2023-12-01 |
| JP2023550446A5 true JP2023550446A5 (https=) | 2024-11-25 |
Family
ID=73698744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530329A Pending JP2023550446A (ja) | 2020-11-20 | 2021-11-19 | 抗ｃｄ２５抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240002522A1 (https=) |
| EP (1) | EP4247497A1 (https=) |
| JP (1) | JP2023550446A (https=) |
| KR (1) | KR20230118108A (https=) |
| CN (1) | CN116917318A (https=) |
| AR (1) | AR124123A1 (https=) |
| AU (1) | AU2021380966A1 (https=) |
| CA (1) | CA3199006A1 (https=) |
| WO (1) | WO2022106665A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023222886A1 (en) | 2022-05-20 | 2023-11-23 | Depth Charge Ltd | Antibody-cytokine fusion proteins |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US61816A (en) | 1867-02-05 | bunbab and a | ||
| US96973A (en) | 1869-11-16 | saxton | ||
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DE3572982D1 (en) | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
| WO1990006952A1 (fr) | 1988-12-22 | 1990-06-28 | Kirin-Amgen, Inc. | Facteur de stimulation de colonies de granulocytes modifies chimiquement |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| US5714350A (en) | 1992-03-09 | 1998-02-03 | Protein Design Labs, Inc. | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region |
| SE9400088D0 (sv) | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
| EP0983303B1 (en) | 1997-05-21 | 2006-03-08 | Biovation Limited | Method for the production of non-immunogenic proteins |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| DK1071700T3 (da) | 1998-04-20 | 2010-06-07 | Glycart Biotechnology Ag | Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet |
| CA2704600C (en) | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| ES2252261T3 (es) | 2000-06-28 | 2006-05-16 | Glycofi, Inc. | Metodos para producir glicoproteinas modificadas. |
| CA2430013C (en) | 2000-11-30 | 2011-11-22 | Medarex, Inc. | Transgenic transchromosomal rodents for making human antibodies |
| CA2463879C (en) | 2001-10-25 | 2012-12-04 | Genentech, Inc. | Glycoprotein compositions |
| PL2602323T3 (pl) | 2007-06-01 | 2018-06-29 | Open Monoclonal Technology, Inc. | Kompozycje i sposoby hamowania endogennych genów immunoglobin i wytwarzania transgenicznych ludzkich przeciwciał typu idiotypowego |
| US11879014B2 (en) * | 2017-03-17 | 2024-01-23 | Tusk Therapeutics Ltd. | Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody |
| EP3649153B8 (en) * | 2017-07-06 | 2025-07-16 | Tusk Therapeutics Ltd | Fc optimised anti-cd25 antibodies for tumor specific cell depletion |
| US10752691B2 (en) * | 2018-03-13 | 2020-08-25 | Tusk Therapeutics Ltd. | Anti-CD25 antibody agents |
| EP3972997A1 (en) * | 2019-05-20 | 2022-03-30 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Novel anti-cd25 antibodies |
-
2021
- 2021-11-19 EP EP21807150.4A patent/EP4247497A1/en active Pending
- 2021-11-19 AR ARP210103224A patent/AR124123A1/es unknown
- 2021-11-19 WO PCT/EP2021/082383 patent/WO2022106665A1/en not_active Ceased
- 2021-11-19 AU AU2021380966A patent/AU2021380966A1/en not_active Abandoned
- 2021-11-19 CN CN202180090876.8A patent/CN116917318A/zh active Pending
- 2021-11-19 CA CA3199006A patent/CA3199006A1/en active Pending
- 2021-11-19 US US18/253,493 patent/US20240002522A1/en active Pending
- 2021-11-19 KR KR1020237019908A patent/KR20230118108A/ko active Pending
- 2021-11-19 JP JP2023530329A patent/JP2023550446A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7143452B2 (ja) | ＣＤ４７とＳＩＲＰａの相互作用を遮断できる抗体及びその応用 | |
| US11203633B2 (en) | Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv | |
| JP2022031635A5 (https=) | ||
| RU2019141289A (ru) | АНТИ-SIRPα АНТИТЕЛА | |
| KR20220024729A (ko) | B-세포 성숙 항원을 표적으로 하는 다중특이성 항체에 대한 투여 요법 및 병용 요법 | |
| JP2021501162A5 (https=) | ||
| JP2023123726A5 (https=) | ||
| RU2019140602A (ru) | АНТИ-GARP-TGF-β-АНТИТЕЛА | |
| JP2019527194A5 (https=) | ||
| JP2020513791A5 (https=) | ||
| JP2020511947A5 (https=) | ||
| JP2017535257A5 (https=) | ||
| JP2016505546A5 (https=) | ||
| HRP20190605T1 (hr) | Protutijela anti-fxi i postupci njihove uporabe | |
| JP2012525829A5 (https=) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2022538733A5 (https=) | ||
| JP2024532489A5 (https=) | ||
| JP2024541680A5 (https=) | ||
| JP2024016024A5 (https=) | ||
| JP2018093875A5 (https=) | ||
| JP2021525806A5 (https=) | ||
| JP2021511387A5 (https=) | ||
| JP2023543493A5 (https=) | ||
| JP2022521305A (ja) | 抗ｐｄ－ｌ１抗体及びその使用 |